• Profile
Close

Coronary computed tomography angiography vs myocardial single photon emission computed tomography in patients with intermediate risk chest pain: A randomized clinical trial for cost-effectiveness comparison based on real-world cost

European Heart Journal – Cardiovascular Imaging Jul 29, 2018

Lee SP, et al. - In this study, coronary computed tomography angiography (CCTA) and myocardial single photon emission computed tomography (SPECT) were compared in terms of cost-effectiveness in patients with stable intermediate risk chest pain. The study included non-acute patients with 10–90% pre-test probability of coronary artery disease from three high-volume centers in Korea (n=965). Findings demonstrated an association of CCTA with fewer subsequent invasive coronary angiography (ICA) with no difference in downstream outcome. They observed that in Korean patients with stable, intermediate risk chest pain, CCTA may be more cost-effective than SPECT.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay